Cabozantinib (XL184) has a high disease control rate for a variety of advanced cancers and can shrink or even eliminate bone metastases. Cabozantinib (XL184) has broad-spectrum anti-cancer capabilities: kidney cancer, liver cancer, lung cancer, thyroid cancer, etc.
Let us work together to protect precious health